Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021

We estimated SARS-CoV-2 vaccine effectiveness against onward transmission by comparing secondary attack rates among household members for vaccinated and unvaccinated index cases, based on source and contact tracing data collected when the Delta variant was dominant. Effectiveness of full vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: de Gier, Brechje, Andeweg, Stijn, Backer, Jantien A, Hahné, Susan JM, van den Hof, Susan, de Melker, Hester E, Knol, Mirjam J, Hofhuis, Agnetha, Teirlinck, Anne, van Lier, Alies, Boudewijns, Bronke, de Dreu, Miek, Valk, Anne-Wil, Jongenotter, Femke, Verstraten, Carolien, Broekhaar, Gert, Willekens, Guido, Veldhuijzen, Irene, Polman, Jan, van de Kassteele, Jan, Alblas, Jeroen, van Heereveld, Janneke, Heijne, Janneke, Bulsink, Kirsten, Wielders, Lieke, van Asten, Liselotte, Jenniskens, Liz, Soetens, Loes, Mulder, Maarten, Schipper, Maarten, de Lange, Marit, Smorenburg, Naomi, Neppelenbroek, Nienke, van den Berg, Patrick, de Oliveira Bressane Lima, Priscila, van Gaalen, Rolina, Wijburg, Sara, Abbas Zadeh, Shahabeh, de Bruijn, Siméon, van Iersel, Senna, Wierenga, Sjoerd, Lanooij, Susan, Keijser, Sylvia, Smit, Tara, Klinkenberg, Don, de Boer, Pieter, McDonald, Scott, Maxwell, Amber, Niessen, Annabel, Berry, Danytza, van Wees, Daphne, van Meijeren, Dimphey, Vos, Eric RA, Dijkstra, Frederika, Kemmeren, Jeanet, Ainslie, Kylie, Middeldorp, Marit, Kooijman, Marjolein, Faber, Timor, Jan van Hoek, Albert, Geubbels, Eveline, van Benthem, Birgit, Wallinga, Jacco, van Gageldonk-Lafeber, Rianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569927/
https://www.ncbi.nlm.nih.gov/pubmed/34738514
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.44.2100977
_version_ 1784594740790951936
author de Gier, Brechje
Andeweg, Stijn
Backer, Jantien A
Hahné, Susan JM
van den Hof, Susan
de Melker, Hester E
Knol, Mirjam J
Hofhuis, Agnetha
Teirlinck, Anne
van Lier, Alies
Boudewijns, Bronke
de Dreu, Miek
Valk, Anne-Wil
Jongenotter, Femke
Verstraten, Carolien
Broekhaar, Gert
Willekens, Guido
Veldhuijzen, Irene
Polman, Jan
van de Kassteele, Jan
Alblas, Jeroen
van Heereveld, Janneke
Heijne, Janneke
Bulsink, Kirsten
Wielders, Lieke
van Asten, Liselotte
Jenniskens, Liz
Soetens, Loes
Mulder, Maarten
Schipper, Maarten
de Lange, Marit
Smorenburg, Naomi
Neppelenbroek, Nienke
van den Berg, Patrick
de Oliveira Bressane Lima, Priscila
van Gaalen, Rolina
Wijburg, Sara
Abbas Zadeh, Shahabeh
de Bruijn, Siméon
van Iersel, Senna
Wierenga, Sjoerd
Lanooij, Susan
Keijser, Sylvia
Smit, Tara
Klinkenberg, Don
de Boer, Pieter
McDonald, Scott
Maxwell, Amber
Niessen, Annabel
Berry, Danytza
van Wees, Daphne
van Meijeren, Dimphey
Vos, Eric RA
Dijkstra, Frederika
Kemmeren, Jeanet
Ainslie, Kylie
Middeldorp, Marit
Kooijman, Marjolein
Faber, Timor
Jan van Hoek, Albert
Geubbels, Eveline
van Benthem, Birgit
Wallinga, Jacco
van Gageldonk-Lafeber, Rianne
author_facet de Gier, Brechje
Andeweg, Stijn
Backer, Jantien A
Hahné, Susan JM
van den Hof, Susan
de Melker, Hester E
Knol, Mirjam J
Hofhuis, Agnetha
Teirlinck, Anne
van Lier, Alies
Boudewijns, Bronke
de Dreu, Miek
Valk, Anne-Wil
Jongenotter, Femke
Verstraten, Carolien
Broekhaar, Gert
Willekens, Guido
Veldhuijzen, Irene
Polman, Jan
van de Kassteele, Jan
Alblas, Jeroen
van Heereveld, Janneke
Heijne, Janneke
Bulsink, Kirsten
Wielders, Lieke
van Asten, Liselotte
Jenniskens, Liz
Soetens, Loes
Mulder, Maarten
Schipper, Maarten
de Lange, Marit
Smorenburg, Naomi
Neppelenbroek, Nienke
van den Berg, Patrick
de Oliveira Bressane Lima, Priscila
van Gaalen, Rolina
Wijburg, Sara
Abbas Zadeh, Shahabeh
de Bruijn, Siméon
van Iersel, Senna
Wierenga, Sjoerd
Lanooij, Susan
Keijser, Sylvia
Smit, Tara
Klinkenberg, Don
de Boer, Pieter
McDonald, Scott
Maxwell, Amber
Niessen, Annabel
Berry, Danytza
van Wees, Daphne
van Meijeren, Dimphey
Vos, Eric RA
Dijkstra, Frederika
Kemmeren, Jeanet
Ainslie, Kylie
Middeldorp, Marit
Kooijman, Marjolein
Faber, Timor
Jan van Hoek, Albert
Geubbels, Eveline
van Benthem, Birgit
Wallinga, Jacco
van Gageldonk-Lafeber, Rianne
author_sort de Gier, Brechje
collection PubMed
description We estimated SARS-CoV-2 vaccine effectiveness against onward transmission by comparing secondary attack rates among household members for vaccinated and unvaccinated index cases, based on source and contact tracing data collected when the Delta variant was dominant. Effectiveness of full vaccination of the index case against transmission to unvaccinated and fully vaccinated household contacts, respectively, was 63% (95% confidence interval (CI): 46–75) and 40% (95% CI: 20–54), in addition to the direct protection of vaccination of contacts against infection.
format Online
Article
Text
id pubmed-8569927
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-85699272021-11-18 Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021 de Gier, Brechje Andeweg, Stijn Backer, Jantien A Hahné, Susan JM van den Hof, Susan de Melker, Hester E Knol, Mirjam J Hofhuis, Agnetha Teirlinck, Anne van Lier, Alies Boudewijns, Bronke de Dreu, Miek Valk, Anne-Wil Jongenotter, Femke Verstraten, Carolien Broekhaar, Gert Willekens, Guido Veldhuijzen, Irene Polman, Jan van de Kassteele, Jan Alblas, Jeroen van Heereveld, Janneke Heijne, Janneke Bulsink, Kirsten Wielders, Lieke van Asten, Liselotte Jenniskens, Liz Soetens, Loes Mulder, Maarten Schipper, Maarten de Lange, Marit Smorenburg, Naomi Neppelenbroek, Nienke van den Berg, Patrick de Oliveira Bressane Lima, Priscila van Gaalen, Rolina Wijburg, Sara Abbas Zadeh, Shahabeh de Bruijn, Siméon van Iersel, Senna Wierenga, Sjoerd Lanooij, Susan Keijser, Sylvia Smit, Tara Klinkenberg, Don de Boer, Pieter McDonald, Scott Maxwell, Amber Niessen, Annabel Berry, Danytza van Wees, Daphne van Meijeren, Dimphey Vos, Eric RA Dijkstra, Frederika Kemmeren, Jeanet Ainslie, Kylie Middeldorp, Marit Kooijman, Marjolein Faber, Timor Jan van Hoek, Albert Geubbels, Eveline van Benthem, Birgit Wallinga, Jacco van Gageldonk-Lafeber, Rianne Euro Surveill Rapid Communication We estimated SARS-CoV-2 vaccine effectiveness against onward transmission by comparing secondary attack rates among household members for vaccinated and unvaccinated index cases, based on source and contact tracing data collected when the Delta variant was dominant. Effectiveness of full vaccination of the index case against transmission to unvaccinated and fully vaccinated household contacts, respectively, was 63% (95% confidence interval (CI): 46–75) and 40% (95% CI: 20–54), in addition to the direct protection of vaccination of contacts against infection. European Centre for Disease Prevention and Control (ECDC) 2021-11-04 /pmc/articles/PMC8569927/ /pubmed/34738514 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.44.2100977 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
de Gier, Brechje
Andeweg, Stijn
Backer, Jantien A
Hahné, Susan JM
van den Hof, Susan
de Melker, Hester E
Knol, Mirjam J
Hofhuis, Agnetha
Teirlinck, Anne
van Lier, Alies
Boudewijns, Bronke
de Dreu, Miek
Valk, Anne-Wil
Jongenotter, Femke
Verstraten, Carolien
Broekhaar, Gert
Willekens, Guido
Veldhuijzen, Irene
Polman, Jan
van de Kassteele, Jan
Alblas, Jeroen
van Heereveld, Janneke
Heijne, Janneke
Bulsink, Kirsten
Wielders, Lieke
van Asten, Liselotte
Jenniskens, Liz
Soetens, Loes
Mulder, Maarten
Schipper, Maarten
de Lange, Marit
Smorenburg, Naomi
Neppelenbroek, Nienke
van den Berg, Patrick
de Oliveira Bressane Lima, Priscila
van Gaalen, Rolina
Wijburg, Sara
Abbas Zadeh, Shahabeh
de Bruijn, Siméon
van Iersel, Senna
Wierenga, Sjoerd
Lanooij, Susan
Keijser, Sylvia
Smit, Tara
Klinkenberg, Don
de Boer, Pieter
McDonald, Scott
Maxwell, Amber
Niessen, Annabel
Berry, Danytza
van Wees, Daphne
van Meijeren, Dimphey
Vos, Eric RA
Dijkstra, Frederika
Kemmeren, Jeanet
Ainslie, Kylie
Middeldorp, Marit
Kooijman, Marjolein
Faber, Timor
Jan van Hoek, Albert
Geubbels, Eveline
van Benthem, Birgit
Wallinga, Jacco
van Gageldonk-Lafeber, Rianne
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
title Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
title_full Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
title_fullStr Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
title_full_unstemmed Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
title_short Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
title_sort vaccine effectiveness against sars-cov-2 transmission to household contacts during dominance of delta variant (b.1.617.2), the netherlands, august to september 2021
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569927/
https://www.ncbi.nlm.nih.gov/pubmed/34738514
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.44.2100977
work_keys_str_mv AT degierbrechje vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT andewegstijn vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT backerjantiena vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT hahnesusanjm vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vandenhofsusan vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT demelkerhestere vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT knolmirjamj vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT hofhuisagnetha vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT teirlinckanne vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vanlieralies vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT boudewijnsbronke vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT dedreumiek vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT valkannewil vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT jongenotterfemke vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT verstratencarolien vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT broekhaargert vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT willekensguido vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT veldhuijzenirene vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT polmanjan vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vandekassteelejan vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT alblasjeroen vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vanheereveldjanneke vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT heijnejanneke vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT bulsinkkirsten vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT wielderslieke vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vanastenliselotte vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT jenniskensliz vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT soetensloes vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT muldermaarten vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT schippermaarten vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT delangemarit vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT smorenburgnaomi vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT neppelenbroeknienke vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vandenbergpatrick vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT deoliveirabressanelimapriscila vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vangaalenrolina vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT wijburgsara vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT abbaszadehshahabeh vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT debruijnsimeon vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vanierselsenna vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT wierengasjoerd vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT lanooijsusan vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT keijsersylvia vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT smittara vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT klinkenbergdon vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT deboerpieter vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT mcdonaldscott vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT maxwellamber vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT niessenannabel vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT berrydanytza vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vanweesdaphne vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vanmeijerendimphey vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vosericra vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT dijkstrafrederika vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT kemmerenjeanet vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT ainsliekylie vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT middeldorpmarit vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT kooijmanmarjolein vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT fabertimor vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT janvanhoekalbert vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT geubbelseveline vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vanbenthembirgit vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT wallingajacco vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021
AT vangageldonklafeberrianne vaccineeffectivenessagainstsarscov2transmissiontohouseholdcontactsduringdominanceofdeltavariantb16172thenetherlandsaugusttoseptember2021

Ejemplares similares